Novavax (NVAX) Director Buys 200K Shares
- Wall Street closes rollercoaster week sharply lower
- Invesco (IVZ) Reportedly in Talks to Merge With State Street's (STT) Asset Management Business, Citi Sees More Cons than Pros
- FDA Votes "No" on Pfizer (PFE) Booster for 16+ Age Group, 2 Yes 16 No
- Jefferies Raises Price Targets on Alphabet (GOOGL) and Facebook (FB) as They Are Still Inexpensive Relative to Growth, Reiterates Snap (SNAP) as a Best Growth Idea
- Tesla (TSLA) Could Deliver 900K EV Units This Year and 1.3M in 2022 - Wedbush
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Novavax (NASDAQ: NVAX) sees continued insider buying. Today, Director, Richard Douglas, disclosed the purchase of 200,000 shares made on 05/11 at $0.93
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novavax (NVAX) to Compare Mixed COVID-19 Vaccine Schedules in Adolescents in a New Phase 2 Study With University of Oxford
- MP Materials (MP) Shares Down 3% Following 4M Share Stock Offering by Firm Controlled by Chairman & CEO James Litinsky
- VEON Ltd. (VEON) CEO Purchases Additional 100K Shares
Create E-mail Alert Related CategoriesHot Insider Trades, Insider Trades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!